Published Year:2021
Molecular Diagnostics Market - A Global and Regional Analysis: Focus on Product, Testing Location, A
The global molecular diagnostics market is projected to reach $24,228.0 million by 2031 from...
A quick peek into the report
Market Report Coverage
Nucleic Acid Isolation and Purification Market
Forecast Period: 2021-2031
CAGR During Forecast Period: 7.20%
Key Questions Answered in this Report:
What are the major market drivers, challenges, and opportunities in the global nucleic acid isolation and purification market?
Report Summary
The market is favored by the increased research activities based on next-generation sequencing-based technologies.
Table of Contents
1.1 Inclusion and Exclusion
2.1 Scope of the Study
3.1 Global Nucleic Acid Isolation and Purification Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
4.1 Definitions
4.1.1 Product Definition
4.1.2 Definition by Products
4.1.2.1 Instruments
4.1.2.2 Column-Based Instruments
4.1.2.3 Bead-Based Instruments
4.1.2.4 Low-Throughput Instruments
4.1.2.5 Medium-Throughput Instruments
4.1.2.6 High-Throughput Instruments
4.1.2.7 Kits
4.1.2.8 Reagents
4.2 Nucleic Acid Isolation and Purification Automation Applications
4.2.1 Genomic/Plasmid DNA Extraction
4.2.2 Cell-Free DNA (cfDNA) Extraction
4.2.3 Viral RNA Extraction
4.2.4 Cell-Free RNA Extraction
4.3 Market Size and Growth Potential, $Million, 2020-2031
4.3.1 North America
4.3.2 Europe, Middle East & Africa (EMEA)
4.3.3 Asia-Pacific (APAC)
4.3.4 Latin America
4.4 Market Attractiveness: Macro and Micro Factor Analysis
4.5 Impact of COVID-19 Pandemic on Nucleic Acid Isolation and Purification Market
4.6 Market Dynamics
4.7 Impact Analysis
4.8 Market Drivers
4.8.1 Growing Number of Genetic Tests
4.8.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results
4.8.3 Rise in the Prevalence of Infectious Disease
4.8.4 Rise in the Field of Microbial Sequencing
4.8.5 Increasing Research Funding in the Field of Molecular Biology
4.8.6 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
4.8.7 Decreasing Cost of Sequencing
4.9 Market Restraints
4.9.1 Genomic Data Protection
4.9.2 High Cost of Automated Instruments
4.9.3 Rigid Regulatory Standards
4.10 Market Opportunities
4.10.1 Evolution of Biobanking in Healthcare
4.10.2 Capitalizing on the High Prevalence of Genetic Disorders
4.10.3 Growth in Emerging Nations
4.10.4 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets
5.1 Key Developments
5.1.1 Product Launches and Enhancements
5.1.2 Collaborations and Agreements
5.1.3 Acquisitions
5.1.4 Business Expansions
5.2 Industry Trends
5.2.1 Emergence of Advanced Stabilization Products
5.2.2 Regulated vs. Multimodal Analysis
5.2.3 Novel Targets for Isolation and Purification
5.2.4 Exploring New Applications
5.2.5 Other Key Trends
6.1 Satisfaction Level of Different Instruments (by Brand)
6.2 Pricing Analysis of Preferred Instruments
6.3 Pricing Analysis - Accessories and Components
6.4 Pricing Analysis – Consumables
7.1 Introduction
7.2 Consumables
7.2.1 Kits
7.2.2 Reagents
7.3 Instruments
8.1 By Workflow
8.1.1 Sample Isolation/Extraction/Purification
8.1.2 DNA/RNA Clean-Up and Concentration
8.1.3 DNA and RNA Quantification
8.2 By Analyte
8.2.1 DNA
8.2.2 RNA
9.1 Cell-Free
9.1.1 By Sample
9.1.1.1 Blood
9.1.1.2 Serum/Plasma
9.1.1.3 Other Sources
9.1.2 By Application
9.1.2.1 Parental and Hereditary Testing
9.1.2.2 Tumor Testing
9.1.2.3 Transplantation
9.2 Genomic
9.2.1 Blood
9.2.2 Body Fluids
9.2.3 Buccal
9.2.4 Cell/Cultured Cell
9.2.5 FFPE
9.2.6 Forensic
9.2.7 Plant
9.2.8 Saliva/Swab
9.2.9 Serum/Plasma
9.2.10 Tissue
9.2.11 Stool, Urine, and Other Samples
9.3 Microbe
9.3.1 Bacterial
9.3.2 Fungus
9.3.3 Yeast
9.3.4 Other Sources
9.4 Plasmid
9.4.1 GigaPrep
9.4.2 MaxiPrep
9.4.3 MegaPrep
9.4.4 MidiPrep
9.4.5 MiniPrep
9.5 Viral
10.1 Genomic RNA
10.1.1 Blood
10.1.2 Body Fluids
10.1.3 Cell/Cultured Cell
10.1.4 FFPE
10.1.5 Plant
10.1.6 Saliva/Swab
10.1.7 Serum/Plasma
10.1.8 Tissue
10.1.9 Urine
10.1.10 Others
10.2 Microbial RNA
10.2.1 Bacteria
10.2.2 Yeast
10.2.3 Fungus
10.2.4 Others
10.3 Viral RNA
10.4 Cell-Free RNA
10.4.1 Serum/Plasma
10.4.2 Others
11.1 Silica-Based
11.2 Magnetic Particle Technology
11.3 Other Technologies
12.1 PCR
12.2 qPCR
12.3 NGS
12.4 Cloning
12.5 Microarray
12.6 Blotting Techniques
12.7 Other Applications
13.1 Introduction
13.2 Academic Research Institutes and Laboratories
13.3 Pharmaceutical and Biotechnology Companies
13.4 Contract Research Organizations
13.5 Applied Testing
13.6 Clinical Diagnostic Centers
14.1 North America
14.1.1 U.S.
14.1.2 Canada
14.2 Europe, Middle East & Africa (EMEA)
14.3 Latin America (LATAM)
14.4 Asia-Pacific
14.4.1 China
14.4.2 Japan
14.4.3 Rest-of-APAC
15.1 Introduction
15.2 Nucleic Acid Isolation and Purification Instrument Market (by Workflow)
15.2.1 Isolation/Extraction/Purification
15.2.2 Quality Control/Quantification
15.3 Nucleic Acid Isolation and Purification Instrument Market (by Technology)
15.3.1 Automated Spin Column-Based Instruments
15.3.2 Magnetic Bead-based Instruments
15.3.3 Automated Liquid Handling Instruments
15.4 Nucleic Acid Isolation and Purification Instrument Market (by Throughput)
15.4.1 Low Throughput Instruments
15.4.2 Medium Throughput Instruments
15.4.3 High Throughput Instruments
15.5 Quality Control/Quantification Instruments (by Technology)
15.5.1 Spectrophotometer
15.5.2 Fluorometers
15.5.3 Others
15.6 Nucleic Acid Isolation and Purification Instrument Market (by End User)
15.6.1 Academic Research Institutes
15.6.2 Pharmaceutical and Biotechnology Companies
15.6.3 Clinical Diagnostic Centers
15.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
15.6.5 Contract Research Organizations
15.7 Nucleic Acid Isolation and Purification Instrument Market (by Region)
15.7.1 North America
15.7.1.1 U.S.
15.7.1.2 Canada
15.7.2 Europe, Middle East and Africa
15.7.3 Asia-Pacific
15.7.3.1 China
15.7.3.2 Japan
15.7.3.3 Rest-of-APAC
15.7.4 Latin America
16.1 Market Share Analysis (Regional and Global)
16.1.1 Global
16.1.2 North America
16.1.3 EMEA
16.2 Growth Share Matrix by End User
16.3 Growth Share Matrix by Region
16.4 Growth Share Matrix by Products
17.1 Key Takeaways
17.2 Gap Analysis
17.3 Business Expansion Opportunity Mapping
17.3.1 By Product
17.3.2 By Region
17.4 Investment Opportunities
17.5 SWOT Analysis
17.6 Propitious Strategies to Succeed in Nucleic Acid Isolation and Purification Market
18.1 Overview
18.2 Agilent Technologies, Inc.
18.2.1 Company Overview
18.2.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.2.3 Financials
18.2.4 Key Insights About Financial of the Company
18.2.5 SWOT Analysis
18.3 Analytik Jena AG
18.3.1 Company Overview
18.3.2 Role of Analytik Jena AG in the Global Nucleic Acid Isolation and Purification Market
18.3.3 SWOT Analysis
18.4 AutoGen, Inc.
18.4.1 Company Overview
18.4.2 Role of Autogen, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.4.3 SWOT Analysis
18.5 Bio-Rad Laboratories, Inc.
18.5.1 Company Overview
18.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.5.3 Financials
18.5.4 Key Insights About Financial Health of the Company
18.5.5 SWOT Analysis
18.6 F. Hoffmann-La Roche AG
18.6.1 Company Overview
18.6.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Isolation and Purification Market
18.6.3 Financials
18.6.4 Key Insights About Financial Health of the Company
18.6.5 SWOT Analysis
18.7 Illumina, Inc.
18.7.1 Company Overview
18.7.2 Role of Illumina, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.7.3 Financials
18.7.4 Key Insights About Financial Health of the Company
18.7.5 SWOT Analysis
18.8 Merck KGaA
18.8.1 Company Overview
18.8.2 Role of Merck KGaA in the Global Nucleic Acid Isolation and Purification Market
18.8.3 Financials
18.8.4 Key Insights About Financial Health of the Company
18.8.5 SWOT Analysis
18.9 Meridian Bioscience, Inc.
18.9.1 Company Overview
18.9.2 Role of Meridian Bioscience in the Global Nucleic Acid Isolation and Purification Market
18.9.3 Financials
18.9.4 Key Insights about Financial Health of the Company
18.9.5 SWOT Analysis
18.10 Macherey-Nagel GmbH & Co KG
18.10.1 Company Overview
18.10.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Isolation and Purification Market
18.10.3 SWOT Analysis
18.11 New England Biolabs, Inc
18.11.1 Company Overview
18.11.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.11.3 SWOT Analysis
18.12 Norgen Biotek Corp.
18.12.1 Company Overview
18.12.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Isolation and Purification Market
18.12.3 SWOT Analysis
18.13 Omega Bio-tek, Inc.
18.13.1 Company Overview
18.13.2 Role of Omega Bio-tek, Inc., in the Global Nucleic Acid Isolation and Purification Market
18.13.3 SWOT Analysis
18.14 Orasure Technologies, Inc.
18.14.1 Company Overview
18.14.2 Role of Orasure Technologies in the Global Nucleic Acid Isolation and Purification Market
18.14.3 Financials
18.14.4 Key Insights about Financial Health of the Company
18.14.5 SWOT Analysis
18.15 PerkinElmer, Inc.
18.15.1 Company Overview
18.15.2 Role of PerkinElmer, Inc. in the Nucleic Acid Isolation and Purification Market
18.15.3 Financials
18.15.4 SWOT Analysis
18.16 Promega Corporation
18.16.1 Company Overview
18.16.2 Role of Promega Corporation in the Global Nucleic Acid Isolation and Purification Market
18.16.3 SWOT Analysis
18.17 QIAGEN N.V.
18.17.1 Company Overview
18.17.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Isolation and Purification Market
18.17.3 Financials
18.17.4 Key Insights About Financial Health of the Company
18.17.5 SWOT Analysis
18.18 Sage Science, Inc.
18.18.1 Company Overview
18.18.2 Role of Sage Science, Inc. in the Global Nucleic Acid Isolation and Purification Market
18.18.3 SWOT Analysis
18.19 Tecan Group
18.19.1 Company Overview
18.19.2 Role of Tecan Group in the Global Nucleic Acid Isolation and Purification Market
18.19.3 Financials
18.19.4 Key Insights about Financial Health of the Company
18.19.5 SWOT Analysis
18.20 ThermoFisher Scientific Inc.
18.20.1 Company Overview
18.20.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Isolation and Purification Market
18.20.3 Financials
18.20.4 Key Insights About Financial Health of the Company
18.20.5 SWOT Analysis
18.21 Zymo Research
18.21.1 Company Overview
18.21.2 Role of Zymo Research in the Global Nucleic Acid Isolation and Purification Market
18.21.3 SWOT Analysis
18.22 Emerging Companies
Table 4.1: Likert Scale
Table 4.2: Impact Analysis of Market Drivers
Table 4.3: Impact Analysis of Market Restraints
Table 4.4: Other Key Research Funding for Nucleic Acid Extraction
Table 5.1: Commercially Available CTC Isolation Technologies
Table 5.2: Key Market Players Offering Ultra Pure Extraction Kits
Table 6.1: Key Automated DNA Extraction/Isolation/Purification and Quantification/Quality Control Systems Price and Material Cost per Sample
Table 6.2: Pricing of Market Available Consumables
Table 11.1: Other Technologies Consumables Market, $Million, 2020-2031
Table 13.1: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2020-2031
Table 13.2: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2020-2031
Table 13.3: Contract Research Organizations Consumables Market (by Analyte), $Million, 2020-2031
Table 13.4: Applied Testing Consumables Market, (by Analyte) $Million, 2020-2031
Table 13.5: Clinical Diagnostic Center Consumables Market (by Analyte), $Million, 2020-2031
Table 14.1: Global Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020-2031
Table 14.2: Global DNA Isolation and Purification Kits Market (by Region), $Million, 2020-2031
Table 14.3: Global RNA Isolation and Purification Kits Market (by Region), $Million, 2020-2031
Table 14.4: Global Nucleic Acid Isolation and Purification Reagents Market (by Region), $Million, 2020-2031
Table 14.5: North America Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
Table 14.6: North America DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.7: North America RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.8: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
Table 14.9: EMEA Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
Table 14.10: EMEA DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.11: EMEA RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.12: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
Table 14.13: LATAM Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
Table 14.14: LATAM DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.15: LATAM RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.16: APAC Nucleic Acid Isolation and Purification Consumables Market (by Country), $Million, 2020-2031
Table 14.17: APAC Nucleic Acid Isolation and Purification Consumables Market (by Analyte), $Million, 2020-2031
Table 14.18: APAC DNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 14.19: APAC RNA Isolation and Purification Kits Market (by Source), $Million, 2020-2031
Table 15.1: Key Isolation/Extraction/Purification Systems for Nucleic Acids
Table 15.2: Key Quality Control/Quantification Systems for Nucleic Acids
Table 15.3: Key Column-Based Systems for Nucleic Acid Extraction
Table 15.4: Key Magnetic Bead-Based Systems for Nucleic Acid Extraction
Table 15.5: Key Automated Liquid Handling Instruments for Nucleic Acid Extraction
Table 15.6: Key Low Throughput Systems for Nucleic Acid Extraction
Table 15.7: Key Medium Throughput Systems for Nucleic Acid Extraction
Table 15.8: Key High Throughput Systems for Nucleic Acid Extraction
Table 15.9: Key Spectrophotometer Systems for Quality Control/Quantification
Table 15.10: Key Fluorometers Systems for Quality Control/Quantification
Table 15.11: Key Other Systems for Quality Control/Quantification
Table 15.12: Collaborations in Genetics and Genomics Research in Africa, by Funder
Table 17.1: Major Issues in Research Laboratories in the Asia-Pacific Region
Table 17.2: Funding Scenario in the Competitive Genomic Landscape
Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
Figure 2: Impact Analysis on the Global Nucleic Acid Isolation and Purification Market
Figure 3: Nucleic Acid Isolation and Purification Market, (by Product), $Million, 2020 vs. 2031
Figure 4: Nucleic Acid Isolation and Purification Consumables Market, (by Type), $Million, 2020 vs. 2031
Figure 5: Nucleic Acid Isolation and Purification Consumables Market, (by Technology), $Million, 2020 vs. 2031
Figure 6: Nucleic Acid Isolation and Purification Consumables Market, (by End User), $Million, 2020 vs. 2031
Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market Snapshot, (by Region) 2020 and 2031
Figure 8: Nucleic Acid Isolation and Purification Instrument Market, (by Technology), $Million, 2020 vs. 2031
Figure 9: Nucleic Acid Isolation and Purification Instrument Market, (by Throughput), $Million, 2020 vs. 2031
Figure 10: Global Nucleic Acid Isolation and Purification Instrument Market Snapshot, (by Region)
Figure 2.1: Global Nucleic Acid Isolation and Purification Market Segmentation
Figure 3.1: Global Nucleic Acid Isolation and Purification Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Forecast Methodology
Figure 4.1: North America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.2: EMEA Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.3: Asia-Pacific Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.4: Latin America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.5: Market Attractiveness Based on Key Characteristics
Figure 4.6: Impact of COVID-19 on the Global Nucleic Acid Isolation and Purification Market
Figure 4.5: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 4.6: Key Genetic Disorder Prevalence in the U.S., 2012-2017
Figure 5.1: Share of Key Developments and Strategies
Figure 6.1: Nucleic Acid Isolation and Purification Customer Preference (by Major Brand), N=27
Figure 6.2: Nucleic Acid Isolation and Purification Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=27)
Figure 7.1: Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020 and 2031
Figure 7.2: Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 7.3: Nucleic Acid Isolation and Purification Kits Market, $Million, 2020-2031
Figure 7.4: Nucleic Acid Isolation and Purification Reagents Market, $Million, 2020-2031
Figure 7.5: Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 8.1: Nucleic Acid Isolation and Purification Kits Market (by Workflow), $Million, 2020 and 2031
Figure 8.2: Sample Isolation/Extraction/Purification Kits Market, $Million, 2020-2031
Figure 8.3: DNA/RNA Clean-Up and concentration Kits Market, $Million, 2020-2031
Figure 8.4: DNA and RNA Quantification Kits Market, $Million, 2020-2031
Figure 8.5: Nucleic Acid Isolation and Purification Kits Market (by Analyte), $Million, 2020 and 2031
Figure 8.6: DNA Kits Market, $Million, 2020-2031
Figure 8.7: Market Share for DNA Kits Market, $Million, 2020
Figure 8.8: RNA Kits Market, $Million, 2020-2031
Figure 8.9: Market Share for RNA Kits Market, $Million, 2020
Figure 9.1: DNA Isolation and Purification Kits Market (by Source Type), $Million, 2020 and 2031
Figure 9.2: Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.3: Market Share for Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.4: Cell-Free DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
Figure 9.5: Cell-Free DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
Figure 9.6: Cell-Free DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
Figure 9.7: Cell-Free DNA Isolation and Purification Kits Market for Prenatal and Hereditary Testing, $Million, 2020-2031
Figure 9.8: Cell-Free DNA Isolation and Purification Kits Market for Tumor Testing, $Million, 2020-2031
Figure 9.9: Cell-Free DNA Isolation and Purification Kits Market for Transplantation, $Million, 2020-2031
Figure 9.10: Genomic DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.11: Market Share for Genomic DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.12: Genomic DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
Figure 9.13: Market Share for Genomic DNA Isolation and Purification Market for Blood, $Million, 2020
Figure 9.14: Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, 2020-2031
Figure 9.15: Market Share for Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, (2020)
Figure 9.16: Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020-2031
Figure 9.17: Market Share for Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020
Figure 9.18: Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020-2031
Figure 9.19: Market Share for Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020
Figure 9.20: Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020-2031
Figure 9.21: Market Share for Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020
Figure 9.22: Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020-2031
Figure 9.23: Market Share for Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020
Figure 9.24: Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020-2031
Figure 9.25: Market Share for Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020
Figure 9.26: Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020-2031
Figure 9.27: Market Share for Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020
Figure 9.28: Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
Figure 9.29: Market Share for Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020
Figure 9.30: Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020-2031
Figure 9.31: Market Share for Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020
Figure 9.32: Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2020-2031
Figure 9.33: Market Share for Genomic DNA Isolation and Purification Kits Market for Stool, Urine, and Other Samples, $Million, 2020
Figure 9.34: Microbe DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.35: Market Share for Microbe DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.36: Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020-2031
Figure 9.37: Market Share for Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020
Figure 9.38: Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020-2031
Figure 9.39: Market Share for Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020
Figure 9.40: Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020-2031
Figure 9.41: Market Share for Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020
Figure 9.42: Microbial DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
Figure 9.43: Plasmid DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.44: Market Share for Plasmid DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.45: Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.46: Market Share for Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.47: Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.48: Market Share for Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.49: Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.50: Market Share for Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.51: Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.52: Market Share for Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.53: Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.54: Market Share for Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.55: Viral DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.56: Market Share for Viral DNA Isolation and Purification Kits Market, $Million, 2020
Figure 10.1: RNA Isolation and Purification Kits Market, $Million, 2020 and 2031
Figure 10.2: Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.3: Genomic RNA Kits Market Share, 2020
Figure 10.4: Genomic RNA Kits for Blood Market, $Million, 2020-2031
Figure 10.5: Genomic RNA Extraction Kits from Blood, Market Share, 2020
Figure 10.6: Body Fluids Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.7: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.8: Cell/Cultured Cell Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.9: FFPE Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.10: FFPE Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.11: Plant Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.12: Plant Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.13: Saliva/Swab Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.14: Serum/Plasma Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.15: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.16: Tissue Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.17: Tissue Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.18: Urine Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.19: Other Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.20: Microbial RNA Kits Market, $Million, 2020-2031
Figure 10.21: Microbial RNA Kits Market Share, 2020
Figure 10.22: Bacterial RNA Kits Market, $Million, 2020-2031
Figure 10.23: Bacterial RNA Kits Market Share, 2020
Figure 10.24: Yeast RNA Kits Market, $Million, 2020-2031
Figure 10.25: Yeast RNA Kits Market Share, 2020
Figure 10.26: Fungus RNA Kits Market, $Million, 2020-2031
Figure 10.27: Fungal RNA Kits Market Share, 2020
Figure 10.28: Other Microbial RNA Kits Market, $Million, 2020-2031
Figure 10.29: Viral RNA Kits Market, $Million, 2020-2031
Figure 10.30: Viral RNA Kits Market Share, 2020
Figure 10.31: Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 10.32: cell-free RNA Kits Market Share, 2020
Figure 10.33: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 10.34: Other Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 11.1: Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020 and 2031
Figure 11.2: Silica-Based Consumables Market, $Million, 2020-2031
Figure 11.3: Magnetic Particle-based Consumables Market, $Million, 2020-2031
Figure 12.1: Nucleic Acid Isolation and Purification Consumables Market (by Technological Downstream Applications), $Million, 2020 and 2031
Figure 12.2: PCR Market, $Million, 2020-2031
Figure 12.3: qPCR Market, $Million, 2020-2031
Figure 12.4: NGS Market, $Million, 2020-2031
Figure 12.5: Cloning Market, $Million, 2020-2031
Figure 12.6: Microarray Market, $Million, 2020-2031
Figure 12.7: Blotting Techniques Market, $Million, 2020-2031
Figure 12.8: Other Applications Market, $Million, 2020-2031
Figure 13.1: Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020 and 2031
Figure 13.2: Academic Research Institutes and Laboratories Market, $Million, 2020-2031
Figure 13.3: Pharmaceutical and Biotechnology Companies Market, $Million, 2020-2031
Figure 13.4: Contract Research Organizations Market, $Million, 2020-2031
Figure 13.5: Applied Testing Market, $Million, 2020-2031
Figure 13.6: Clinical Diagnostic Center Market, $Million, 2020-2031
Figure 14.1: Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020 and 2031
Figure 14.2: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.3: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.4: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.5: EMEA Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.6: LATAM Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.7: APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.8: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.9: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.10: Rest-of-APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 15.1: Nucleic Acid Isolation and Purification Instrument Market (by Workflow), $Million, 2020 and 2031
Figure 15.2: Isolation/Extraction/Purification Instrument Market, $Million, 2020-2031
Figure 15.3: Quality Control/Quantification Instrument Market, $Million, 2020-2031
Figure 15.4: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Technology), $Million, 2020 and 2031
Figure 15.5: Automated Spin Column-Based Instrument Market, $Million, 2020-2031
Figure 15.6: Magnetic Bead-based Instrument Market, $Million, 2020-2031
Figure 15.7: Automated Liquid Handling Instruments Market, $Million, 2020-2031
Figure 15.8: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Throughput), $Million, 2020 and 2031
Figure 15.9: Low Throughput Instrument Market, $Million, 2020-2031
Figure 15.10: Medium Throughput Instrument Market, $Million, 2020-2031
Figure 15.11: High Throughput Instrument Market, $Million, 2020-2031
Figure 15.12: Quality Control/Quantification Instruments, (by Technology), $Million, 2020 and 2031
Figure 15.13: Spectrophotometers Market, $Million, 2020-2031
Figure 15.14: Fluorometers Market, $Million, 2020-2031
Figure 15.15: Others Market, $Million, 2020-2031
Figure 15.16: Nucleic Acid Isolation and Purification Instrument Market (by End User), $Million, 2020 and 2031
Figure 15.17: Nucleic Acid Isolation and Purification Instrument Market for Academic Research Institutes, $Million, 2020-2031
Figure 15.18: Nucleic Acid Isolation and Purification Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2020-2031
Figure 15.19: Nucleic Acid Isolation and Purification Instrument Market for Clinical Diagnostic Centers, $Million, 2020-2031
Figure 15.20: Nucleic Acid Isolation and Purification Instrument Market for Applied Testing, $Million, 2020-2031
Figure 15.21: Nucleic Acid Isolation and Purification Instrument Market for Contract Research Organizations, $Million, 2020-2031
Figure 15.22: Nucleic Acid Isolation and Purification Instrument Market (by Region), $Million, 2020 and 2031
Figure 15.23: North America Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.24: North America Nucleic Acid Isolation and Purification Instrument Market (by Country), $Million, 2020-2031
Figure 15.25: U.S. Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.26: Canada Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.27: EMEA Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.28: APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.29: APAC Nucleic Acid Isolation and Purification Instrument Market (by Country) $Million, 2020-2031
Figure 15.30: China Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.31: Japan Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.32: Rest-of-APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.33: LATAM Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 16.1: Market Share Analysis for the Global Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.2: Market Share Analysis for the Global Nucleic Acid Isolation and Purification Instrument Market, 2020
Figure 16.3: Global Nucleic Acid Isolation and Purification Kits Market Share, 2020
Figure 16.4: Market Share Analysis for the North America Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.5: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Instrument Market, 2018
Figure 16.6: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Kits Market, 2020
Figure 16.7: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.8: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Instrument Market, 2020
Figure 16.9: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Kits Market, 2020
Figure 16.10: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by End User)
Figure 16.11: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Region)
Figure 16.12: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Product)
Figure 17.1: Business Expansion Opportunity Mapping (by Product)
Figure 17.2: Business Expansion Opportunity Mapping (by Region)
Figure 17.3: Nucleic Acid Isolation and Purification Market: SWOT Analysis
Figure 18.1: Total Number of Companies Profiles
Figure 18.2: Agilent Technologies, Inc.: Key Product Portfolio
Figure 18.3: Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 18.4: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 18.5: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 18.6: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 18.7: Agilent Technologies, Inc.: SWOT Analysis
Figure 18.8: Analytik Jena AG: Key Product Portfolio
Figure 18.9: Analytik Jena AG: SWOT Analysis
Figure 18.10: AutoGen, Inc.: Key Product Portfolio
Figure 18.11: AutoGen, Inc.: SWOT Analysis
Figure 18.12: Bio-Rad Laboratories, Inc.: Key Product Portfolio
Figure 18.13: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
Figure 18.14: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2018-2020
Figure 18.15: Bio-Rad Laboratories, Inc.: Sales (by Region), 2018-2020
Figure 18.16: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
Figure 18.17: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 18.18: F. Hoffmann-La Roche AG: Key Product Portfolio
Figure 18.19: F. Hoffmann-La Roche AG: Overall Financials, 2018-2020
Figure 18.20: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2018-2020
Figure 18.21: F. Hoffmann-La Roche AG: Revenue (by Region), 2018-2020
Figure 18.22: F. Hoffmann-La Roche AG: R&D Expenditure, 2018-2020
Figure 18.23: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 18.24: Illumina, Inc.: Key Product Portfolio
Figure 18.25: Illumina, Inc.: Overall Financials, 2018-2020
Figure 18.26: Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 18.27: Illumina, Inc.: Revenue (by Region), 2018-2020
Figure 18.28: Illumina, Inc.: R&D Expenditure, 2018-2020
Figure 18.29: Illumina, Inc.: SWOT Analysis
Figure 18.30: Merck KGaA: Key Product Offerings
Figure 18.31: Merck KGaA: Overall Financials, 2018-2020
Figure 18.32: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
Figure 18.33: Merck KGaA: Revenue (by Region), 2018-2020
Figure 18.34: Merck KGaA: R&D Expenditure, 2018-2020
Figure 18.35: Merck KGaA: SWOT Analysis
Figure 18.36: Meridian Bioscience: Key Product Portfolio
Figure 18.37: Meridian Bioscience: Overall Financials, 2018-2020
Figure 18.38: Meridian Bioscience Revenue (by Segment), 2018-2020
Figure 18.39: Meridian Bioscience: Revenue (by Region), 2018-2020
Figure 18.40: Meridian Bioscience: R&D Expenditure, 2018-2020
Figure 18.41: Meridian Bioscience: SWOT Analysis
Figure 18.42: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
Figure 18.43: Macherey-Nagel GmbH & Co KG: SWOT Analysis
Figure 18.44: New England Biolabs, Inc: Key Product Offerings
Figure 18.45: New England Biolabs, Inc.: SWOT Analysis
Figure 18.46: Norgen Biotek Corp.: Key Product Portfolio
Figure 18.47: Norgen Biotek Corp.: SWOT Analysis
Figure 18.48: Omega Bio-tek, Inc.: Key Product Portfolio
Figure 18.49: Omega Bio-Tek: SWOT Analysis
Figure 18.50: Orasure Technologies, Inc.: Key Product Portfolio
Figure 18.51: Orasure Technologies, Inc.: Overall Financials, 2018-2020
Figure 18.52: Orasure Technologies, Inc. Revenue (by Segment), 2018-2020
Figure 18.53: Orasure Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 18.54: Orasure Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 18.55: Orasure Technologies, Inc.: SWOT Analysis
Figure 18.56: PerkinElmer, Inc.: Key Product Portfolio
Figure 18.57: Perkin Elmer, Inc.: Overall Financials, (2018-2020)
Figure 18.58: Perkin Elmer, Inc.: Revenue (by Business Segment), 2018-2020
Figure 18.59: Perkin Elmer, Inc.: Revenue (by Region), 2018-2020
Figure 18.60: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
Figure 18.61: PerkinElmer, Inc.: SWOT Analysis
Figure 18.62: Promega Corporation: Key Product Portfolio
Figure 18.63: Promega Corporation: SWOT Analysis
Figure 18.64: QIAGEN N.V.: Key Product Offerings
Figure 18.65: QIAGEN N.V.: Overall Financials, 2018-2020
Figure 18.66: QIAGEN N.V.: Revenue (by Segment), 2018-2020
Figure 18.67: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 18.68: QIAGEN N.V.: R&D Expenditure, 2018-2020
Figure 18.69: QIAGEN N.V.: SWOT Analysis
Figure 18.70: Sage Science, Inc.: Key Product Portfolio
Figure 18.71: Sage Science, Inc.: SWOT Analysis
Figure 18.72: Tecan Group: Key Product Portfolio
Figure 18.73: Tecan Group: Overall Financials, 2018-2020
Figure 18.74: Tecan Group Revenue (by Segment), 2018-2020
Figure 18.75: Tecan Group: Revenue (by Region), 2018-2020
Figure 18.76: Tecan Group: R&D Expenditure, 2018-2020
Figure 18.77: Tecan Group: SWOT Analysis
Figure 18.78: Thermo Fisher Scientific Inc.: Key Product Offerings
Figure 18.79: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 18.80: Thermo Fisher Scientific Inc: Sales (by Segment), $Million, 2018-2020
Figure 18.81: Thermo Fisher Scientific Inc.: Sales (by Region), 2018-2020
Figure 18.82: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 18.83: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 18.84: Zymo Research: Key Product Portfolio
Figure 18.85: Zymo Research: SWOT Analysis
Market Report Coverage
|
Nucleic Acid Isolation and Purification Market |
|||
|
Base Year |
2020 |
Market Size in 2020 |
$2,304.7 Million |
|
Forecast Period |
2021-2031 |
Value Projection and Estimation by 2031 |
$5,010.3 Million |
|
CAGR During Forecast Period |
7.20% |
Number of Tables |
47 |
|
Number of Pages |
395 |
Number of Figures |
290 |
|
Market Segmentation |
• Product Type- Instruments and Consumables (Kits and Reagents) • End User – Academic and Research Institutions, Biopharmaceutical and Biotechnological, Companies, Contract Research Organizations, Applied Testing, Clinical Diagnostic Centers, and Other End Users |
||
|
Regional Segmentation |
• North America – U.S., Canada • Europe, Middle East & Africa (EMEA) • Asia-Pacific – China, Japan, and Rest-of-Asia-Pacific (RoAPAC) • Latin America (LATAM) |
||
|
Growth Drivers |
• Growing Number of Genetic Tests • Increasing Demand for Reliable Next-Generation Sequencing (NGS) Results • Rise in the Prevalence of Infectious Disease • Rise in the Field of Microbial Sequencing • Increasing Research Funding in the Field of Molecular Biology • Increase in Awareness and Acceptance of Personalized Medicines on a Global Level • Decreasing Cost of Sequencing |
||
|
Market Challenges |
• Genomic Data Protection • High Cost of Automated Instruments • Rigid Regulatory Standards |
||
|
Market Opportunities |
• Evolution of Biobanking in Healthcare • Capitalizing on the High Prevalence of Genetic Disorders • Growth in Emerging Nations • Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets |
||
|
Key Companies Profiled |
Agilent Technologies, Inc., Analytik Jena AG, AutoGen, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Merck KGaA, Meridian Bioscience, Inc., Macherey-Nagel GmbH & Co KG, New England Biolabs, Inc, Norgen Biotek Corp., Omega Bio-tek, Inc., Orasure Technologies, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Sage Science, Inc., Tecan Group, ThermoFisher Scientific Inc., Zymo Research |
||
Key Questions Answered in this Report:
• What are the major market drivers, challenges, and opportunities in the global nucleic acid isolation and purification market?
• What are the key development strategies which are being implemented by major players in order to sustain in the competitive market?
• How each segment of the market is expected to grow during the forecast period from 2020 to 2029 based on
o Product type: instrument and consumables (kits and reagents)
o End User: academic research institutes, pharmaceutical and biotechnology companies, applied testing, contract research organizations, and clinical diagnostic centers
o Region: North America, EMEA, Asia-Pacific, and Latin America
• Which are the leading players with significant offerings to the global nucleic acid isolation and purification market? What is the expected market dominance for each of these leading players?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the challenges in the nucleic acid isolation and purification market?
Report Summary
BIS Research healthcare experts have found the nucleic acid isolation and purification market to be one of the growing markets, which is predicted to grow at a CAGR of 7.20% during the forecast period, 2021-2031. The nucleic acid isolation and purification market growth has been primarily attributed to the major drivers in this market, such as growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious diseases, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, high cost of automated instruments, and rigid regulatory standards are some of the factors expected to retrain the market growth.
Figure: Global Nucleic Acid Isolation and Purification Market Snapshot
The market is favored by the increased research activities based on next-generation sequencing-based technologies. The consumable segment has been segmented to into DNA and RNA sample type, among which RNA sample type is expected to growth at a highest CAGR of 7.70% during the forecast period 2021-2031. This increase is mainly attributed to the large number of research and development being conducted due to the COVID-19 pandemic, specifically considering viral RNA sample.
Within the research report, the market is segmented on the basis of product type, end users, and region. The kits segment is further segment into DNA and RNA, to gain holistic view of the industry. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the downstream application such as next-generation sequencing, polymerase chain reaction, and other techniques used for COVID-19 testing on the global level has created a buzz among companies to invest in the development of extraction RNA free severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests. Due to technologically advanced solutions and intense market penetration, companies such as Qiagen N.V., Promega Corporation, and Thermo Fisher Scientific, Inc. have been a pioneer and a significant competitor in this market.
Other key players in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F.Hoffmann-La Roche AG, Illumina, Inc., General Electric Company (GE), and New England Biolabs, among others.
With the increasing demand for complex and custom sequencing techniques, rising genetic testing services, and growing research to treat and diagnose genetic and infectious diseases, companies have the opportunity to expand their product portfolios, increasing automation facilitation, and develop novel techniques for nucleic acid extraction by adopting different strategic approaches. Some of the strategies followed by the contributors are new product launches and enhancements, agreements, collaborations, partnerships, acquisitions, and expansions. For instance, in 2020, Promega Corporation has launched Wizard HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA, which enables researchers to obtain DNA that will provide strong performance in long-read sequencing applications in a 90-minute manual protocol.
The nucleic acid isolation and purification market has immensely propelled by nationwide sequencing activities, focusing on generating large genomic libraries for research and development purpose. For instance, Illumina, Inc. has invested $60.0 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation and other public and private entities. Under the contract, Illumina, Inc. will donate next-generation sequencing (NGS) platforms, reagents, and training support worth approximately US $60 million over five years.
FAQ's
What is the estimated growth rate of global nucleic acid isolation and purification market in the coming years?
The global nucleic acid isolation and purification market was estimated at $2,304.7 Million in 2020 and is expected to grow at a CAGR of 7.20% from 2021 to 2031.
What are the possible opportunities that can boost the growth of the global nucleic acid isolation and purification market?
Opportunities that can boost the growth of the global nucleic acid isolation and purification market, include evolution of biobanking in healthcare, capitalizing on the high prevalence of genetic disorders, and growth in emerging nations.
What are factors driving the growth of global nucleic acid isolation and purification market?
The factors driving the growth of the global nucleic acid isolation and purification market include growing number of genetic tests, increasing demand for reliable next-generation sequencing (NGS) results, rise in the prevalence of infectious disease, and rise in the field of microbial sequencing.
What are the end-users of the global nucleic acid isolation and purification market?
The end-users of the market, include Academic and Research Institutions, Biopharmaceutical and Biotechnological, Companies, Contract Research Organizations, Applied Testing, Clinical Diagnostic Centers, and Other End Users.
Which are the top market players operating in the global nucleic acid isolation and purification market?
Agilent Technologies, Inc., Analytik Jena AG, AutoGen, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., Merck KGaA, Meridian Bioscience, Inc., Macherey-Nagel GmbH & Co KG, New England Biolabs, Inc, Norgen Biotek Corp., Omega Bio-tek, Inc., Orasure Technologies, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Sage Science, Inc., Tecan Group, ThermoFisher Scientific Inc., Zymo Research.
You may also like
Published Year:2020
Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Coun
The single cell sequencing industry analysis by BIS Research projects the market to grow at a...
Published Year:2019
Global Molecular Diagnostics Point of Care Market: Focus on Application, Technology, Type, End User,
The global molecular diagnostic point of care industry analysis by BIS Research projects the...
Published Year:2019
Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,
In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...
Global Nucleic Acid Isolation and Purification Market
Focus on Product, End User, Region/Country Data and Competitive Landscape - Analysis and Forecast, 2021-2031